Concepedia

Rajesh Nanta

RN

4

Publications

430

Citations

4

H-Index

2013

Active since

Affiliations

University of Kansas Medical Center(Current)

Kansas City VA Medical Center

University of Missouri–Kansas City

The University of Kansas Cancer Center

Rajesh Nanta is an author at University of Kansas Medical Center specializing in tumor biology, cell biology, and medicine.

Top concepts

Publications per year

2013–2018

4

Publications

4

PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth

N. K. Sharma, Rajesh Nanta, Jay Sharma et al. · Oncotarget · 2015 · 158 citations · Full text

, , +16

NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200

Junsheng Fu, Marianna Rodova, Rajesh Nanta et al. · Neuro-Oncology · 2013 · 105 citations · Full text

NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128

Rajesh Nanta, Dhruv Kumar, Daniel G. Meeker et al. · Oncogenesis · 2013 · 103 citations · Full text

, , +20

Inhibition of sonic hedgehog and PI3K/Akt/mTOR pathways cooperate in suppressing survival, self-renewal and tumorigenic potential of glioblastoma-initiating cells

Rajesh Nanta, Anju Shrivastava, Jay Sharma et al. · Molecular and Cellular Biochemistry · 2018 · 64 citations

, , +9

Rows per page

1–4 of 4